Intracranial Stents Market - By Type: Aneurysm Stents, Intracranial Atherosclerotic Disease (ICAD) Stents, Flow-Diverting Stents; By Design: Laser-Cut Stents, Braided Stents, Dual-Layer Hybrid Stents; By End User: Hospitals, Neurology & Neurosurgery Centers, Ambulatory Neurovascular Clinics; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global intracranial stents market is experiencing significant growth, fueled by the increasing prevalence of ischemic stroke, wide-neck aneurysms, and the adoption of endovascular neurosurgery. Intracranial stents—small expandable devices placed in cerebral arteries—are utilized to maintain vessel patency and facilitate coil placement in aneurysm treatment, or to reopen narrowed arteries in instances of intracranial atherosclerotic disease (ICAD).
Ongoing advancements in stent material science, design (braided vs. laser-cut), and hybrid models have significantly enhanced flexibility, wall apposition, and neurovascular compatibility. With stroke emerging as a leading cause of global mortality and disability, healthcare systems are broadening access to neurointerventional solutions like stenting.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
0.79 |
Historical benchmark |
|
2024 |
1.23 |
Five-year CAGR 9.3% |
|
2031 |
2.42 |
Seven-year CAGR 10.0% |
The market is projected to nearly double by 2031, as demand for less invasive cerebral revascularization and aneurysm support technologies continues to rise.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The intracranial stents market is concentrated among key neurovascular players offering both aneurysm and ICAD-focused products.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Products |
|
Stryker |
28% |
Neuroform Atlas®, Wingspan™ Stent System |
|
MicroVention (Terumo) |
24% |
LVIS™, LVIS Jr., and braided flow-compatible stents |
|
Medtronic |
19% |
Pipeline™ Flex with Shield Technology (flow-diverting) |
|
Balt USA |
11% |
Silk Vista Baby™, Leo+ stents |
|
Others (Phenox, Cerus, InspireMD) |
18% |
Niche and regional access platforms |
6 | Market Segmentation
By Type:
By Design:
By End User:
By Region:
7 | Strategic Outlook
Growth will be influenced by the convergence of artificial intelligence in imaging, drug-eluting neuro stents, and physician training in emerging economies. Partnerships with stroke centers and inclusion in national reimbursement schemes will strengthen penetration in under-treated regions.
Need help?
Chat with our team in a minute.